SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019720
Filing Date
2021-08-13
Accepted
2021-08-13 16:16:18
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 970305
2 ex31.htm EX-31 22250
3 ex32.htm EX-32 5358
  Complete submission text file 0001493152-21-019720.txt   5857852

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE age-20210630.xsd EX-101.SCH 38354
5 XBRL CALCULATION FILE age-20210630_cal.xml EX-101.CAL 69906
6 XBRL DEFINITION FILE age-20210630_def.xml EX-101.DEF 183958
7 XBRL LABEL FILE age-20210630_lab.xml EX-101.LAB 351703
8 XBRL PRESENTATION FILE age-20210630_pre.xml EX-101.PRE 278491
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1144944
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 211172357
SIC: 2834 Pharmaceutical Preparations